Rosiglitazone and Insulin in T1DM Adolescents

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

September 30, 2005

Conditions
Type 1 DiabetesPuberty: >Tanner 2 Breast Development or Testis >4ml
Interventions
DRUG

Rosiglitazone

Trial Locations (1)

2038

Sydney Children's Hospital, Sydney

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sydney Children's Hospitals Network

OTHER

collaborator

National Health and Medical Research Council, Australia

OTHER

collaborator

Novo Nordisk A/S

INDUSTRY

lead

The University of New South Wales

OTHER